US Patent 12065487 Antigen-binding molecules and uses thereof

Is a

Patent

Patent attributes

Patent Applicant

Scout Bio (Company)

Current Assignee

Scout Bio (Company)

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120654870

Patent Inventor Names

Matthew J. Wilson0

Samantha J. Busfield0

Date of Patent

August 20, 2024

Patent Application Number

183390940

Date Filed

June 21, 2023

Patent Citations

‌

US Patent 7282199 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

‌

US Patent 7439065 Helper virus-free AAV production

‌

US Patent 7588772 AAV capsid library and AAV capsid proteins

‌

US Patent 7906111 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

‌

US Patent 7790449 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor

‌

US Patent 6951753 Helper-free stocks of recombinant adeno-associated virus vectors

‌

US Patent 7094604 Production of pseudotyped recombinant AAV virions

‌

US Patent 7172893 Virus vectors and methods of making and administering the same

...

Patent Primary Examiner

‌

Marianne P Allen

Patent abstract

The present disclosure relates to an antigen-binding molecule that specifically binds to nerve growth factor (NGF) and uses thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12065487 Antigen-binding molecules and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12065487 Antigen-binding molecules and uses thereof